IL135256A0 - 2- substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) - Google Patents

2- substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)

Info

Publication number
IL135256A0
IL135256A0 IL13525698A IL13525698A IL135256A0 IL 135256 A0 IL135256 A0 IL 135256A0 IL 13525698 A IL13525698 A IL 13525698A IL 13525698 A IL13525698 A IL 13525698A IL 135256 A0 IL135256 A0 IL 135256A0
Authority
IL
Israel
Prior art keywords
ht1d
ht1b
ht1a
substituted
serotonin antagonists
Prior art date
Application number
IL13525698A
Other languages
English (en)
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of IL135256A0 publication Critical patent/IL135256A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
IL13525698A 1997-10-22 1998-10-05 2- substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) IL135256A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19746612A DE19746612A1 (de) 1997-10-22 1997-10-22 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung
PCT/EP1998/006300 WO1999020616A1 (de) 1997-10-22 1998-10-05 2-substituierte 1,2-benzisothiazol-derivate und ihre verwendung als serotonin-antagonisten (5-ht1a, 5-ht1b und 5-ht1d)

Publications (1)

Publication Number Publication Date
IL135256A0 true IL135256A0 (en) 2001-05-20

Family

ID=7846266

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13525698A IL135256A0 (en) 1997-10-22 1998-10-05 2- substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)

Country Status (23)

Country Link
US (1) US6346622B1 (xx)
EP (1) EP1034170A1 (xx)
JP (1) JP2001520224A (xx)
KR (1) KR20010031297A (xx)
CN (1) CN1277607A (xx)
AR (1) AR016968A1 (xx)
AU (1) AU748613B2 (xx)
BG (1) BG104332A (xx)
BR (1) BR9812948A (xx)
CA (1) CA2307199A1 (xx)
CO (1) CO4980863A1 (xx)
DE (1) DE19746612A1 (xx)
HR (1) HRP980555A2 (xx)
HU (1) HUP0003758A3 (xx)
IL (1) IL135256A0 (xx)
NO (1) NO20001937L (xx)
NZ (1) NZ503604A (xx)
PL (1) PL340033A1 (xx)
SK (1) SK4572000A3 (xx)
TR (1) TR200001080T2 (xx)
TW (1) TW517052B (xx)
WO (1) WO1999020616A1 (xx)
ZA (1) ZA989571B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900544A1 (de) * 1999-01-11 2000-07-13 Basf Ag Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie
JP2006503106A (ja) * 2002-09-17 2006-01-26 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー 統合失調症を処置するためのヘテロ環式置換ピペラジン
US20040127501A1 (en) * 2002-09-24 2004-07-01 Zhengming Chen Therapeutic agents useful for treating pain
DE60334016D1 (de) 2002-11-05 2010-10-14 Glaxo Group Ltd Antibakterielle mittel
KR100472988B1 (ko) 2002-11-27 2005-03-10 씨제이 주식회사 조직감, 취반성 및 안전성이 우수한 발아 현미의 제조방법및 이로부터 얻은 발아 현미
CN101151249B (zh) * 2005-03-31 2011-04-06 辉瑞产品公司 环戊吡啶及四氢喹啉衍生物
KR101682058B1 (ko) * 2008-12-11 2016-12-02 비이브 헬쓰케어 컴퍼니 카르바모일피리돈 ｈｉｖ 인테그라제 억제제를 위한 제조방법 및 중간체
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3620643A1 (de) * 1985-06-22 1987-01-22 Sandoz Ag Thiazole, ihre herstellung und verwendung
NL8601494A (nl) 1985-06-22 1987-01-16 Sandoz Ag Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten.
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2675800A1 (fr) * 1991-04-26 1992-10-30 Rhone Poulenc Rorer Sa Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
JPH0912562A (ja) * 1995-06-22 1997-01-14 Suntory Ltd 置換ベンゾチアジン誘導体

Also Published As

Publication number Publication date
NO20001937D0 (no) 2000-04-13
PL340033A1 (en) 2001-01-15
BR9812948A (pt) 2000-08-08
AR016968A1 (es) 2001-08-01
BG104332A (en) 2001-02-28
WO1999020616A1 (de) 1999-04-29
CO4980863A1 (es) 2000-11-27
KR20010031297A (ko) 2001-04-16
CN1277607A (zh) 2000-12-20
EP1034170A1 (en) 2000-09-13
TW517052B (en) 2003-01-11
US6346622B1 (en) 2002-02-12
NZ503604A (en) 2002-03-01
AU1149799A (en) 1999-05-10
HRP980555A2 (en) 1999-08-31
ZA989571B (en) 2000-04-25
NO20001937L (no) 2000-04-13
TR200001080T2 (tr) 2001-01-22
AU748613B2 (en) 2002-06-06
JP2001520224A (ja) 2001-10-30
SK4572000A3 (en) 2000-10-09
CA2307199A1 (en) 1999-04-29
HUP0003758A3 (en) 2001-12-28
DE19746612A1 (de) 1999-04-29
HUP0003758A1 (hu) 2001-10-28

Similar Documents

Publication Publication Date Title
IS4813A (is) Bensýl íden-Laktam afleiður, framleiðsla þeirra og notkun þeirra sem valvís mót-/gerandefni fyrir 5-HT1A- og/eða 5-HT1D- viðtaka
AU4337699A (en) Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT4 receptors
DE69907964D1 (de) 1,2-annelierte chinolinderivate
MXPA02008801A (es) Derivados de indol, proceso para la preparacion de los mismos y su uso.
HK1047743A1 (en) New use and novel n-azabicyclo-amide derivatives.
ATE435861T1 (de) 12,13-cyclopropan-epothilonderivate
AU5265599A (en) Amine compounds, their production and their use as somatostatin receptor antagonists or agonists
ID28695A (id) TURUNAN-TURUNAN BENZO (b) TIEPIN 1,1-DIOKSIDA, PROSES PENYIAPAN, SEDIAAN FARMASI YANG MENGANDUNG SENYAWA-SENYAWA INI, DAN PENGGUNAANNYA
HK1046909A1 (en) Piperazine derivatives as 5-ht1b antagonists.
AU6636598A (en) Novel 3,4-dialkoxyphenyl derivatives and the use thereof
ATE266637T1 (de) 3,3-biarylpiperidin- und 3,3- biarylmorpholinderivate
GR3034408T3 (en) Piperazine derivatives and their use as 5-ht1a antagonists
HUP0003758A3 (en) 2-substituted 1,2-benzisothiazole derivatives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)
NO20003825L (no) 1,3,4 - oxadiazolonderivater
HUP0100926A3 (en) Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists
FI972306A0 (fi) Substituoituja 2-aryylikarbonyylioksimetyyli-1,2,5-tiadiatsolidin -3- oni-1,1-dioksidi-johdannaisia ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
AU9068398A (en) 3-substituted 3,4,5,7-tetrahydro-pyrrolo3',4':4,5 thieno2,3-dpyrimidine derivatives, their preparation and use as 5ht antagonists
IL136501A0 (en) Pharmaceutical compositions containing the leukotrpharmaceutical compositions containing the leukotriene antagonist zafirlukast, process for their preiene antagonist zafirlukast, process for their preparation and use thereof paration and use thereof
PT963985E (pt) Derivados de di- ou triaza-espiro(4,5)decano
IL156174A0 (en) 1,2,4-oxadizaole derivatives as hppar alpha agonists
AU3076600A (en) 3,7-disubstituted indole derivatives and medicinal compositions containing the same
AU4506499A (en) Novel 2,4-diaminophenol derivatives and the use thereof
AU3147500A (en) Fused 1,4-thiazine-2-carbonitrile derivatives, their preparation and use
ZA99171B (en) Piperazino derivatives as neurokinin antagonists.
AU1970800A (en) 1,4-benzodiazepinone derivatives and their use as integrin antagonists